Novel semi-synthetic compound shows promise against drug-resistant tuberculosis

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains.

Cadaveric pituitary-derived growth hormone delivery influences iatrogenic Alzheimer’s Disease

Recipients of cadaver-derived pituitary growth hormone (c-hGH) developed biomarker changes in the realm of Alzheimer’s disease (AD).

January 31, 2024

Pharmalittle: Supreme Court halts Purdue bankruptcy plan; what to know about compounded obesity drugs

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

August 11, 2023

Gallbladder Cancer Rates Stable or Down, Except in Black Patients

WASHINGTON — While rates of gallbladder cancer have been decreasing in the U.S., this rare but often-deadly cancer is on the rise in Black patients,

May 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.